Literature DB >> 2526577

Nutritional evaluation of Huntington disease patients.

L M Morales1, J Estévez, H Suárez, R Villalobos, L Chacín de Bonilla, E Bonilla.   

Abstract

A nutritional survey and evaluation was made in Huntington disease patients by the 24-h-recall method. Control subjects and choreic patients consumed a diet that supplied all the essential amino acids. The diet was hypocaloric, rich in animal protein, and low in fat and carbohydrates. The ratio of calcium to phosphorus in the groups studied was less than 1. High vitamin A and low vitamin C and niacin intakes were observed in Huntington disease patients. Only 17% of control subjects showed weight deficiency; 55% of the patients at stages III and IV of the disease were malnourished despite receiving the same food intake as controls. Although iron intake was deficient in all groups studied, it was enough to maintain normal serum levels of this metal. The deficiencies found in some nutrients do not explain the clinical manifestations observed in Huntington disease patients.

Entities:  

Mesh:

Year:  1989        PMID: 2526577     DOI: 10.1093/ajcn/50.1.145

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  20 in total

1.  Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Authors:  Karen Marder; Yian Gu; Shirley Eberly; Caroline M Tanner; Nikolaos Scarmeas; David Oakes; Ira Shoulson
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

Review 2.  How vital is sleep in Huntington's disease?

Authors:  Anna O G Goodman; Roger A Barker
Journal:  J Neurol       Date:  2010-03-24       Impact factor: 4.849

3.  Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.

Authors:  Chi-Tso Chiu; Guangping Liu; Peter Leeds; De-Maw Chuang
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

Review 4.  Mutant huntingtin and mitochondrial dysfunction.

Authors:  Ella Bossy-Wetzel; Alejandra Petrilli; Andrew B Knott
Journal:  Trends Neurosci       Date:  2008-10-24       Impact factor: 13.837

5.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

6.  Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.

Authors:  Mahmoud A Pouladi; Yuanyun Xie; Niels Henning Skotte; Dagmar E Ehrnhoefer; Rona K Graham; Jeong Eun Kim; Nagat Bissada; X William Yang; Paolo Paganetti; Robert M Friedlander; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2010-01-22       Impact factor: 6.150

7.  Serum iron, total iron binding capacity and ferritin in early Huntington disease patients.

Authors:  P J Morrison; N C Nevin
Journal:  Ir J Med Sci       Date:  1994-05       Impact factor: 1.568

8.  Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Authors:  K Marder; H Zhao; S Eberly; C M Tanner; D Oakes; I Shoulson
Journal:  Neurology       Date:  2009-08-04       Impact factor: 9.910

9.  Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.

Authors:  Jack Phan; Miriam A Hickey; Peixiang Zhang; Marie-Francoise Chesselet; Karen Reue
Journal:  Hum Mol Genet       Date:  2009-01-05       Impact factor: 6.150

10.  Rate and correlates of weight change in Huntington's disease.

Authors:  J M Hamilton; T Wolfson; G M Peavy; M W Jacobson; J Corey-Bloom
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.